CHAIR
:
SPEAKER
(S):
Mostafa Analoui, MD, Senior Director , Pfizer Global Research & Development
Loic Blum, PhD, Director , Université Claude Bernard Lyon 1
James Gimzewski, PhD, Professor , University of California, Los Angeles
Sungho Jin, PhD, Professor and Director , University of California San Diego
Donald Martin, PhD, Professor , University of Technology, Sydney
Description
"Recent advances have created a new world of "nanomedicine"
covering essential elements of human health management, including nanodiagnostics, nanotherapeutics and
nanobiodevices. There are exciting developments in sensors and devices for reliable and rapid diagnosis of diseases, designing drugs and delivering medical interventions to
patients and designing tiny devices to monitor and control organ functions. International panelists with complementary expertise will describe state-of-the-art advances in
nanomedicine, identify the challenges for human health management and outline future opportunities."
Objective1: Share exciting developments for human health management.
Objective2: "Share vision and importance of the role that biotech and pharmaceutical companies can play in accelerating lab-tobench translation."
Objective3: Generate enthusiasm and an environment for international cooperation/collaboration.